Skip to main content
. 2019 Aug 22;11(9):1229. doi: 10.3390/cancers11091229

Figure 3.

Figure 3

(A) Patient’s distribution by EGFR and ALK status (Standard Approach); (B) patient’s classification by Ion Ampliseq Lung and colon panel plus ALK FISH status (Investigational Approach); (C) distribution of hotspot DNA and RNA subgroups in the clinical cohort (Clinical application of the combined DNA + RNA Panel).